Officials at the US Department of Commerce endorsed the largest merger in corporate history by rubber-stamping the paperwork prior to returning it to the roll in the toilet stall at the lavatory down the hall.
The amalgamation involved the acquisition of all the American pharmaceutical companies by a consortium of Mexican drug cartels.
Soon after Wall Street applauded the deal that was made possible by NAFTA, the stock market crashed because brokers sold all their shares to buy drugs to celebrate the new monopoly.
Investment firms are waiting with baited breath, eagerly anticipating, and even salivating, before a panel of judges finalize the contract subsequent to procuring a substantial bribe or two.
